Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
4 days ago
4
ARTICLE AD BOX
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.